FDA adverse event reporting system (faers) data management program (DMP) support services

Active Indefinite Delivery Contract Awarded Last action

Contract number
75F40123D00012
Awardee
Awarding agency
Task orders
4 $17,149,704 obligated

Award facts

Combined order value
  • $17,149,704 Current, with exercised options
  • $18,490,582 Potential, with all options
Last date to order 68% complete
IDV ceiling 43% used
$40,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 10 offers Negotiated Proposal / Quote
Pricing
Labor Hours

Award details come from SAM.gov/FPDS.

About this IDV

The Food and Drug Administration awarded a single-award indefinite-delivery contract to Mpza LLC, a minority-owned and women-owned small business, on May 26, 2023, with a $40 million ceiling for FDA Adverse Event Reporting System (FAERS) Data Management Program Support Services under a Total Small Business set-aside. The contract extends through May 24, 2028.

Place of performance is Silver Spring, Maryland. The IDIQ supports FDA's operations in processing, managing, and analyzing adverse event reports submitted through FAERS, the agency's critical system for tracking safety concerns related to drugs, biologics, and medical devices.

Recent delivery orders issued under this IDIQ include a $5.49 million time-and-materials order awarded March 2, 2026, extending through March 8, 2027, for continued FAERS data management support at Silver Spring, Maryland; a $438,909.54 firm-fixed-price order awarded September 9, 2024, to process a backlog of adverse event reports for the Office of Cosmetics and Colors, completing August 8, 2025; and a $14.5 million labor-hour order awarded June 6, 2023, for FAERS data management support services with performance through March 8, 2026. The contract has undergone recent amendments incorporating wage rate determination 2015-4269 Revision 32 and adjusting labor rates for General Clerk II and General Clerk III positions in ordering periods 4 and 5.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 · 1. Incorporate wage rate determination 2015-4269 revision 32, dated 05/13/2026; and $0
Supplemental Agreement for work within scope P00002 · 1. Incorporate wage rate determination 2015-4269 revision 28, dated 12/23/2024; and 2. Adjust the labor rates for general clerk II and general clerk III in… $0
Supplemental Agreement for work within scope P00001 $0
Original award $3,000

Quick answers

Who was awarded contract 75F40123D00012?

75F40123D00012 was awarded to Mpza LLC by Food and Drug Administration (Department of Health and Human Services) on May 26, 2023.

How much is contract 75F40123D00012 worth?

Orders under 75F40123D00012 have obligated $17,149,704. Their combined potential value, with all options, is $18,490,582. 75F40123D00012's own ceiling is $40,000,000.

How many orders have been placed under contract 75F40123D00012?

4 orders have been placed under 75F40123D00012, the latest on March 2, 2026.

Who can order from contract 75F40123D00012?

75F40123D00012 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75F40123D00012 competed?

The extent of competition for 75F40123D00012 was full and open competition after exclusion of sources. The government received 10 offers. It was set aside: Total Small Business.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV